7749
MEDIKIT CO.,LTD.
メディキット
- Industry
- Precision Instruments
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Mar 2022
20,130,697
Mar 2023
21,607,233
Mar 2024
21,850,545
Mar 2025
22,553,238
Mar 2026
23,781,456
Operating profit(thousand JPY)
Mar 2022
4,422,776
Mar 2023
4,118,187
Mar 2024
4,677,830
Mar 2025
4,486,793
Mar 2026
4,272,403
Operating profit margin(%)
Mar 2022
21.97
Mar 2023
19.06
Mar 2024
21.41
Mar 2025
19.89
Mar 2026
17.97
Profit before tax(thousand JPY)
Mar 2022
4,472,804
Mar 2023
4,291,340
Mar 2024
4,775,158
Mar 2025
4,659,700
Mar 2026
4,512,196
Profit(thousand JPY)
Mar 2022
2,993,017
Mar 2023
2,864,589
Mar 2024
3,069,466
Mar 2025
3,013,544
Mar 2026
3,006,084
Total assets(thousand JPY)
Mar 2022
51,057,894
Mar 2023
53,186,344
Mar 2024
50,999,470
Mar 2025
52,470,812
Mar 2026
53,272,034
Cash and cash equivalents(thousand JPY)
Mar 2022
18,118,088
Mar 2023
17,592,949
Mar 2024
19,111,087
Mar 2025
17,059,317
Mar 2026
18,652,613
Cash flows from operating activities(thousand JPY)
Mar 2022
3,153,557
Mar 2023
4,480,319
Mar 2024
4,834,465
Mar 2025
3,561,573
Mar 2026
4,734,751
Cash flows from investing activities(thousand JPY)
Mar 2022
-1,719,622
Mar 2023
-3,582,343
Mar 2024
3,230,735
Mar 2025
-3,870,946
Mar 2026
-1,293,143
Cash flows from financing activities(thousand JPY)
Mar 2022
-901,234
Mar 2023
-1,509,626
Mar 2024
-6,584,093
Mar 2025
-1,879,313
Mar 2026
-1,821,371
Return on equity(%)
Mar 2022
6.7
Mar 2023
6.2
Mar 2024
6.7
Mar 2025
6.8
Mar 2026
6.5
Equity ratio(%)
Mar 2022
89.6
Mar 2023
88.9
Mar 2024
86.5
Mar 2025
86.1
Mar 2026
87.8
Earnings per share(JPY per share)
Mar 2022
178.14
Mar 2023
170.67
Mar 2024
187.95
Mar 2025
204.55
Mar 2026
206.37
Net assets per share(JPY per share)
Mar 2022
2,728.04
Mar 2023
2,817.2
Mar 2024
2,982.56
Mar 2025
3,089.58
Mar 2026
3,231.16
Dividend per share(JPY per share)
Mar 2022
60
Mar 2023
100
Mar 2024
80
Mar 2025
90
Mar 2026
100
Payout ratio(%)
Mar 2022
33.68
Mar 2023
58.59
Mar 2024
42.56
Mar 2025
44
Mar 2026
48.46
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.